Xie, Xiaxiang – Trademark Portfolio
Entity Type: 01
Xie, Xiaxiang owns a portfolio of 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GUYW, HCYG, HYLX, SXLM, and TXTP. Of these, 17 are registered. The portfolio spans 7 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 3 (Cosmetics & Cleaning). Headquartered in Wuxuan, Guangxi.
No. 44-1, North Street, Sanli Town,
Wuxuan, Guangxi 545900 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xie, Xiaxiang's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Xie, Xiaxiang have?
Xie, Xiaxiang has 19 U.S. trademarks filed with the USPTO. Of these, 17 registered, 2 abandoned.
What trademark classes does Xie, Xiaxiang file in?
Xie, Xiaxiang files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 16 (Paper Goods), Class 24 (Fabrics), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Xie, Xiaxiang's most well-known trademarks?
Xie, Xiaxiang's registered trademark portfolio includes well-known marks such as GUYW, HCYG, HYLX, SXLM, and TXTP. These are among 17 currently registered trademarks in the portfolio.
What is Xie, Xiaxiang's trademark registration success rate?
Xie, Xiaxiang has a 89% trademark registration rate, with 17 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.